U.S., Aug. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07108621) titled 'hCG Priming in Women With Diminished Ovarian Reserve' on July 11.
Brief Summary: The aim of this randomized controlled trial is to further examine the possible effects of low dose human chorionic gonadotropin (hCG) priming for eight weeks in women with diminished ovarian reserve (DOR) undergoing in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI). The investigators want to retest the findings of our first study in an identical paired design (NCT04643925), as an increase of 1.5 in mean number of oocytes retrieved is clinically relevant. To incorporate the strengths of a randomized controlled trial design, women will b...